Good morning :)
Place Order
Add to Watchlist

Johnson Pharmacare Ltd

JOHNPHARMA Share Price

0.942.17% (+0.02)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹50 cr, stock is ranked 3,529

Stock is 2.54x as volatile as Nifty

JOHNPHARMA Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹50 cr, stock is ranked 3,529

Stock is 2.54x as volatile as Nifty

JOHNPHARMA Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-722.860.89
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.826.380.56%

JOHNPHARMA Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

JOHNPHARMA Company Profile

Johnson Pharmacare Ltd is currently not engaged in any business activities and has not generated any revenues.

JOHNPHARMA Similar Stocks (Peers)

Compare with peers 
PE Ratio
43.35
1Y Return
12.28%
Buy Reco %
88.24
PE Ratio
22.85
1Y Return
3.42%
Buy Reco %
75.00
PE Ratio
67.49
1Y Return
23.16%
Buy Reco %
68.00
PE Ratio
55.31
1Y Return
22.99%
Buy Reco %
81.25
PE Ratio
17.93
1Y Return
5.45%
Buy Reco %
53.33
Compare with Peers

JOHNPHARMA Forecasts

JOHNPHARMA Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

JOHNPHARMA

Income

Balance Sheet

Cash Flow

JOHNPHARMA Income Statement

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.000.050.000.920.000.763.262.530.00
Raw Materialssubtract0.000.000.000.000.000.652.692.020.000.07
Power & Fuel Costsubtract0.000.000.000.000.000.000.000.000.00
Employee Costsubtract0.010.030.030.020.020.020.100.070.00
Selling & Administrative Expensessubtract0.110.090.030.010.070.080.340.210.20
Operating & Other expensessubtract0.010.000.000.90-0.000.01-0.001.550.00
Depreciation/Amortizationsubtract0.000.000.000.000.000.000.000.000.00
Interest & Other Itemssubtract0.000.000.000.000.000.000.000.000.00
Taxes & Other Itemssubtract0.000.000.000.000.000.000.04-0.040.00
EPS-0.00-0.00-0.00-0.00-0.000.000.00-0.02-0.00-0.00
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.00

JOHNPHARMA Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

JOHNPHARMA Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Johnson Pharmacare Ltd-253.000.89
Sun Pharmaceutical Industries Ltd43.356.190.78%
Cipla Ltd22.854.491.07%
Torrent Pharmaceuticals Ltd67.4916.300.85%

JOHNPHARMA Stock Price Comparison

Compare JOHNPHARMA with any stock or ETF
Compare JOHNPHARMA with any stock or ETF
JOHNPHARMA
Loading...

JOHNPHARMA Shareholdings

JOHNPHARMA Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

JOHNPHARMA Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

JOHNPHARMA Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding0.00%0.00%0.00%0.00%100.00%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

JOHNPHARMA Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

JOHNPHARMA Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing JOHNPHARMA stock

Looks like this stock is not in any smallcase yet.

JOHNPHARMA Events

JOHNPHARMA Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

JOHNPHARMA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

JOHNPHARMA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

JOHNPHARMA Stock News & Opinions

Corporate
Johnson Pharmacare to discuss results

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Johnson Pharmacare reports standalone net loss of Rs 0.03 crore in the December 2024 quarter

Net loss of Johnson Pharmacare reported to Rs 0.03 crore in the quarter ended December 2024. There were no net profit/loss reported during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Johnson Pharmacare to announce Quarterly Result

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Johnson Pharmacare reports standalone nil net profit/loss in the September 2024 quarter

Johnson Pharmacare reported no net profit/loss in the quarter ended September 2024 and during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Johnson Pharmacare to table results

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Johnson Pharmacare AGM scheduled

Johnson Pharmacare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Johnson Pharmacare reports standalone net loss of Rs 0.04 crore in the June 2024 quarter

Net Loss of Johnson Pharmacare reported to Rs 0.04 crore in the quarter ended June 2024 as against net loss of Rs 0.19 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Johnson Pharmacare schedules board meeting

Johnson Pharmacare will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Sun and Shine Worldwide renames as ‘Johnson Pharmacare’

3 years agoIndia Infoline

Sun and Shine Worldwide to change its name as ‘Johnson Pharmacare’

3 years agoIndia Infoline

Frequently asked questions

  1. What is the share price of Johnson Pharmacare Ltd (JOHNPHARMA) today?

    The share price of JOHNPHARMA as on 20th May 2025 is ₹0.94. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Johnson Pharmacare Ltd (JOHNPHARMA) share?

    The past returns of Johnson Pharmacare Ltd (JOHNPHARMA) share are
    • Past 1 week: 5.75%
    • Past 1 month: -6.12%
    • Past 3 months: -7.07%
    • Past 6 months: -22.69%
    • Past 1 year: -23.33%
    • Past 3 years: -16.36%
    • Past 5 years: 820%

  3. What are the peers or stocks similar to Johnson Pharmacare Ltd (JOHNPHARMA)?
  4. What is the market cap of Johnson Pharmacare Ltd (JOHNPHARMA) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹50.60 Cr as of 20th May 2025.

  5. What is the 52 week high and low of Johnson Pharmacare Ltd (JOHNPHARMA) share?

    The 52-week high of Johnson Pharmacare Ltd (JOHNPHARMA) is ₹1.44 and the 52-week low is ₹0.81.

  6. What is the PE and PB ratio of Johnson Pharmacare Ltd (JOHNPHARMA) stock?

    The P/E (price-to-earnings) ratio of Johnson Pharmacare Ltd (JOHNPHARMA) is -253. The P/B (price-to-book) ratio is 0.89.

  7. Which sector does Johnson Pharmacare Ltd (JOHNPHARMA) belong to?

    Johnson Pharmacare Ltd (JOHNPHARMA) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Johnson Pharmacare Ltd (JOHNPHARMA) shares?

    You can directly buy Johnson Pharmacare Ltd (JOHNPHARMA) shares on Tickertape. Simply sign up, connect your demat account and place your order.